These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 31678992)
1. Dietary and Pharmacological Fatty Acids and Cardiovascular Health. Wu H; Xu L; Ballantyne CM J Clin Endocrinol Metab; 2020 Apr; 105(4):1030-45. PubMed ID: 31678992 [TBL] [Abstract][Full Text] [Related]
2. Triglyceride-lowering and anti-inflammatory mechanisms of omega-3 polyunsaturated fatty acids for atherosclerotic cardiovascular risk reduction. Liu QK J Clin Lipidol; 2021; 15(4):556-568. PubMed ID: 34172393 [TBL] [Abstract][Full Text] [Related]
3. Role of ω3 long-chain polyunsaturated fatty acids in reducing cardio-metabolic risk factors. Abeywardena MY; Patten GS Endocr Metab Immune Disord Drug Targets; 2011 Sep; 11(3):232-46. PubMed ID: 21831036 [TBL] [Abstract][Full Text] [Related]
4. Effects of omega-3, omega-6, and total dietary polyunsaturated fatty acid supplementation in patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis. Luo S; Hou H; Wang Y; Li Y; Zhang L; Zhang H; Jin Q; Wu G; Wang X Food Funct; 2024 Feb; 15(3):1208-1222. PubMed ID: 38224465 [No Abstract] [Full Text] [Related]
5. Prevention of Cardiovascular Events with Omega-3 Polyunsaturated Fatty Acids and the Mechanism Involved. Watanabe Y; Tatsuno I J Atheroscler Thromb; 2020 Mar; 27(3):183-198. PubMed ID: 31582621 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Impact of Nutritional Supplementation With Omega-3 Fatty Acids: JACC Focus Seminar. Weinberg RL; Brook RD; Rubenfire M; Eagle KA J Am Coll Cardiol; 2021 Feb; 77(5):593-608. PubMed ID: 33538258 [TBL] [Abstract][Full Text] [Related]
7. Emerging nutrition science on fatty acids and cardiovascular disease: nutritionists' perspectives. Kris-Etherton PM; Fleming JA Adv Nutr; 2015 May; 6(3):326S-37S. PubMed ID: 25979506 [TBL] [Abstract][Full Text] [Related]
8. Omega-3 fatty acids for the prevention of atherosclerotic cardiovascular disease. Barry AR; Dixon DL Pharmacotherapy; 2021 Dec; 41(12):1056-1065. PubMed ID: 34431129 [TBL] [Abstract][Full Text] [Related]
9. Fish Oil and Cardiometabolic Diseases: Recent Updates and Controversies. Tummala R; Ghosh RK; Jain V; Devanabanda AR; Bandyopadhyay D; Deedwania P; Aronow WS Am J Med; 2019 Oct; 132(10):1153-1159. PubMed ID: 31077653 [TBL] [Abstract][Full Text] [Related]
10. Treatment with omega-3 polyunsaturated fatty acids does not improve endothelial function in patients with type 2 diabetes and very high cardiovascular risk: A randomized, double-blind, placebo-controlled study (Omega-FMD). Siniarski A; Haberka M; Mostowik M; Gołębiowska-Wiatrak R; Poręba M; Malinowski KP; Gąsior Z; Konduracka E; Nessler J; Gajos G Atherosclerosis; 2018 Apr; 271():148-155. PubMed ID: 29518747 [TBL] [Abstract][Full Text] [Related]
11. Fatty acid concentration of plasma, muscle, adipose and liver from beef heifers fed an encapsulated n-3 polyunsaturated fatty acid supplement. Hennessy AA; Kenny DA; Byrne CJ; Childs S; Ross RP; Devery R; Stanton C Animal; 2021 Jan; 15(1):100039. PubMed ID: 33516004 [TBL] [Abstract][Full Text] [Related]
12. Association between dietary intake of omega-3 polyunsaturated fatty acids and all-cause and cardiovascular mortality among hypertensive adults: Results from NHANES 1999-2018. Chen H; Leng X; Liu S; Zeng Z; Huang F; Huang R; Zou Y; Xu Y Clin Nutr; 2023 Dec; 42(12):2434-2442. PubMed ID: 37871484 [TBL] [Abstract][Full Text] [Related]
13. Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid. Siriwardhana N; Kalupahana NS; Moustaid-Moussa N Adv Food Nutr Res; 2012; 65():211-22. PubMed ID: 22361189 [TBL] [Abstract][Full Text] [Related]
15. Development of a food-exchange model to replace saturated fat with MUFAs and n-6 PUFAs in adults at moderate cardiovascular risk. Weech M; Vafeiadou K; Hasaj M; Todd S; Yaqoob P; Jackson KG; Lovegrove JA J Nutr; 2014 Jun; 144(6):846-55. PubMed ID: 24717370 [TBL] [Abstract][Full Text] [Related]
16. Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids. Burke MF; Burke FM; Soffer DE Curr Atheroscler Rep; 2017 Nov; 19(12):60. PubMed ID: 29116404 [TBL] [Abstract][Full Text] [Related]
17. Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment. Saunders EF; Reider A; Singh G; Gelenberg AJ; Rapoport SI Bipolar Disord; 2015 Nov; 17(7):729-42. PubMed ID: 26424416 [TBL] [Abstract][Full Text] [Related]
18. Dietary Long-Chain n-3 Polyunsaturated Fatty Acid Supplementation Alters Electrophysiological Properties in the Nucleus Accumbens and Emotional Behavior in Naïve and Chronically Stressed Mice. Di Miceli M; Martinat M; Rossitto M; Aubert A; Alashmali S; Bosch-Bouju C; Fioramonti X; Joffre C; Bazinet RP; Layé S Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743093 [TBL] [Abstract][Full Text] [Related]
20. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study. Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]